藥品業務合作交易（2019-2024）

本報告深入了解並分析公司如何以及為何進行業務合作交易。

本報告提供了 2019 年至 2024 年商業夥伴關係交易的詳細資訊。

本報告提供了雙方宣布的業務合作項目的付款條件。這些數據提供了有關支付條款和其他交易條款的寶貴見解。

了解潛在合作夥伴談判條款的彈性，並深入了解談判過程，以了解條款談判期間的預期結果。許多小型企業會要求提供付款條件的詳細信息，但在涉及付款方式和權利如何轉讓時，細節是關鍵。

本報告提供了自2019 年以來宣布的業務合作項目的完整列表，這些項目記錄在當前協議項目/合作夥伴關係資料庫中，並且還包括可用的財務條款。關係文件的線上副本的連結。

主要優點

該報告為讀者提供了以下主要好處：

• 了解 2019 年以來的交易趨勢
• 查看業務夥伴交易
• 基準分析：確定交易的市場價值
• 財務狀況
• 交易清單：依公司名稱 (A-Z)、依治療領域、依技術類型
• 主要交易（金額基礎）
• 最活躍的交易撮合者
• 每筆交易的資產識別和交易條件
• 取得合約文件：深入了解交易結構
• 盡職調查：評估擬議交易條款對合作夥伴公司的適用性
• 節省數百小時的研究時間

調查範圍

• 本報告旨在深入了解全球領先的生物製藥公司之間的業務合作趨勢和交易結構。

此報告包含以下資訊：

• 生物製藥產業商業聯盟交易的趨勢
• 業務合作交易架構：概覽
• 整個製藥業的業務合作交易記錄列表
• 主要業務聯盟交易（金額基礎）
• 最活躍的商業合作交易促成者
• 業務合作的主要合作夥伴資源

此報告列出了可獲得資訊的交易：

• 依公司名稱（A-Z）
• 按交易金額
• 依治療領域
• 依技術型
• 每個交易標題都透過網路連結連結到實際交易記錄的線上版本。
• 此報告提供了對許可協議的可用合約文件的全面存取。

對合約協議的分析允許盡職調查：

• 授予和選擇了哪些權利？
• 合約授予了哪些權利？
• 授予哪些專有權？
• 合約的付款結構是怎樣的？
• 如何審核銷售和付款？
• 合約期限是多久？
• 合約的主要條款是如何定義的？
• 如何對待和擁有知識產權？
• 誰負責商業化？
• 誰負責開發、供應和製造？
• 如何管理保密和發布？
• 如何解決爭議？
• 什麼情況下可以取消合約？
• 如果所有者發生變化會怎樣？
• 已商定何種類型的分授權或分包條款？
• 公司需要哪些樣板條款？
• 哪些樣板條款會根據合作夥伴和交易類型的不同而有所不同？
• 每家公司都主張合約法中的哪一個管轄權？

目錄

執行摘要

第一章簡介

第二章商業合作趨勢

• 簡介
• 業務合作的定義
• 業務合作趨勢（2019年後）
  • 達成的業務合作交易：依年份（2019-2024 年）
  • 已達成的業務合作交易：依發展階段劃分（2019-2024 年）
  • 已達成的業務合作交易：依產業分類（2019-2024 年）
  • 達成的業務合作交易：依治療領域劃分（2019-2024 年）
  • 已達成的業務合作交易：依技術類型劃分（2019-2024 年）
  • 創造業務合作交易：針對最活躍的公司（2019-2024 年）
• 簽訂業務合作/夥伴關係協議的原因
• 業務合作的未來

第三章商業聯盟交易架構概述

• 簡介
• 業務合作結構

第四章主要商業聯盟交易

• 簡介
• 主要業務合作交易（金額基礎）

第五章業務合作最活躍25家供應商

• 簡介
• 前 25 位最活躍的業務夥伴（已完成交易的公司）

第六章業務合作交易清單（含合約明細）

• 簡介
• 業務合作交易協議（2019-2024）
• 交易列表
• 交易清單：已達成的業務合作交易，依公司名稱（A-Z）列出
• 交易清單：已達成的業務合作交易（按治療領域）
• 交易清單：已達成的業務合作交易（依技術類型）

關於懷爾德伍德創投公司

• 目前的合作關係
• 當前合約
• Current Partnering 發布的最新報告標題

Collaboration Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter collaboration deals.

Fully revised and updated, the report provides details of collaboration deals from 2019 to 2024.

The report provides access to collaboration deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaboration contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of collaboration dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in collaboration as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of collaboration deals.

Chapter 4 provides a review of the leading collaboration deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active collaboration dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of collaboration deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

The deal directory includes a comprehensive listing of all collaboration deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in collaboration dealmaking since 2019.

In conclusion, this report provides everything a prospective dealmaker needs to know about collaboration alliances.

Key benefits

Collaboration Deals in Pharmaceuticals provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse collaboration deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Collaboration Deals in Pharmaceuticals is intended to provide the reader with an in-depth understanding of the collaboration trends and structure of deals entered into by leading biopharma companies worldwide.

Collaboration Deals in Pharmaceuticals includes:

• Trends in collaboration dealmaking in the biopharma industry
• Overview of collaboration deal structure
• Directory of collaboration deal records covering pharmaceutical and biotechnology
• The leading collaboration deals by value
• Most active collaboration dealmakers
• The leading collaboration partnering resources

In Collaboration Deals in Pharmaceuticals, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Collaboration Deals in Pharmaceuticals provides comprehensive access to available records for collaboration deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What subcollaboration and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2019
  • 2.3.1. Collaboration dealmaking by year, 2019-2024
  • 2.3.2. Collaboration dealmaking by phase of development, 2019-2024
  • 2.3.3. Collaboration dealmaking by industry sector, 2019-2024
  • 2.3.4. Collaboration dealmaking by therapy area, 2019-2024
  • 2.3.5. Collaboration dealmaking by technology type, 2019-2024
  • 2.3.6. Collaboration dealmaking by most active company, 2019-2024
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts 2019-2024
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type

About Wildwood Ventures

• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deal
• Figure 2: Trends in collaboration deal announcements, 2019-2024
• Figure 3: Collaboration deals signed at each phase of development, 2019-2024
• Figure 4: Collaboration deals by industry sector, 2019-2024
• Figure 5: Collaboration deals by therapy area, 2019-2024
• Figure 6: Collaboration deals by technology type, 2019-2024
• Figure 7: Top 25 most active collaboration dealmakers, 2019-2024
• Figure 8: Top collaboration deals by value, 2019-2024
• Figure 9: Most active collaboration dealmakers, 2019-2024